Piper Sandler maintains ICU Medical at Overweight, raises price target to $200 from $195
Piper Sandler kept ICU Medical at Overweight, raising its price target to $200 from $195, suggesting a 19.3% upside from the Nov 5 close of $167.65.
How this was made

The 30-second read
Why it matters
The upgrade to Overweight and higher target may attract new buying interest.
Market read
A fresh analyst upgrade can prompt immediate buying, offering a short-term trade idea.
What to watch
Potential supply chain constraints not addressed in the note.
Background
Analyst rating updates are common catalysts for short-term price moves.
Ticker impact
Piper Sandler raised its price target for ICU Medical to $200, indicating a fresh bullish view.
likely upward pressure as investors price in the higher target
Target increase from $195 to $200 signals improved expectations, prompting buying interest.
Market effects
May lift sentiment for the medical device sector.
Limited to US markets where ICU trades.
Low
Counterpoint
Target raise could be premature if upcoming earnings miss expectations.
Key entities
- AnalystPiper Sandler
Equity research firm issuing the rating change.
- CompanyICU Medical
Medical device manufacturer whose stock is the subject.